117 related articles for article (PubMed ID: 31277802)
1. The Pitchfork Sign: A Novel OCT Feature of Choroidal Neovascularization in Tuberculosis.
Ramtohul P; Comet A; Denis D
Ophthalmol Retina; 2019 Jul; 3(7):615. PubMed ID: 31277802
[No Abstract] [Full Text] [Related]
2. Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.
Tetikoglu M; Sagdik HM; Aktas S; Ozcura F
Eye (Lond); 2016 Jun; 30(6):894-5. PubMed ID: 26939555
[No Abstract] [Full Text] [Related]
3. Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.
Broadhead GK; Chang A
Graefes Arch Clin Exp Ophthalmol; 2015 Jun; 253(6):979-81. PubMed ID: 25547617
[No Abstract] [Full Text] [Related]
4. Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.
Diago T
Eye (Lond); 2016 Apr; 30(4):637-9. PubMed ID: 26795418
[No Abstract] [Full Text] [Related]
5. Preservation of macular structure and function after intravitreal aflibercept for choroidal neovascularization associated with serpiginous choroiditis.
Schatz P; Skarin A; Lavaque AJ; Lima LH; Arevalo JF
Acta Ophthalmol; 2016 Dec; 94(8):839-841. PubMed ID: 26780597
[No Abstract] [Full Text] [Related]
6. Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.
Padrón-Pérez N; Arias L; Rubio M; Lorenzo D; García-Bru P; Català-Mora J; Caminal JM
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1119-1124. PubMed ID: 29490349
[TBL] [Abstract][Full Text] [Related]
7. Focal choroidal excavation and pitchfork sign in choroidal neovascularisation associated with choroidal osteoma.
Rajabian F; Arrigo A; Grazioli A; Sperti A; Bandello F; Battaglia Parodi M
Eur J Ophthalmol; 2021 Mar; 31(2):NP67-NP70. PubMed ID: 31813301
[TBL] [Abstract][Full Text] [Related]
8. Hyperreflective Foci Number Correlates with Choroidal Neovascularization Activity in Angioid Streaks.
Parodi MB; Arrigo A; Romano F; Aragona E; Marchese A; Cicinelli MV; Mercuri S; Bandello F
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3314-3319. PubMed ID: 30025095
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal aflibercept for choroidal neovascularization in ocular sarcoidosis.
Querques L; Querques G; Miserocchi E; Modorati G; Bandello F
Eur J Ophthalmol; 2016 Aug; 26(5):e124-7. PubMed ID: 26868005
[TBL] [Abstract][Full Text] [Related]
10. Aflibercept for inflammatory choroidal neovascularization with persistent fluid on intravitreal ranibizumab therapy.
Hernández-Martínez P; Dolz-Marco R; Alonso-Plasencia M; Abreu-Gonzalez R
Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1337-9. PubMed ID: 24789465
[No Abstract] [Full Text] [Related]
11. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T
Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
[TBL] [Abstract][Full Text] [Related]
12. Choroidal neovascularisation secondary to serpiginous choroiditis: The value of OCT-angiography in diagnosis and response to therapy with aflibercept.
Campos Polo R; Rubio Sánchez C; Sánchez Trancón A
Arch Soc Esp Oftalmol (Engl Ed); 2019 Sep; 94(9):460-464. PubMed ID: 30733067
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
[TBL] [Abstract][Full Text] [Related]
15. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
[TBL] [Abstract][Full Text] [Related]
16. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
Hara C; Sawa M; Sayanagi K; Nishida K
Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Bevacizumab for Choroidal Neovascular Membrane at the Edge of a Healed Choroidal Tuberculoma.
Tripathy K; Chawla R; Sharma YR
Ocul Immunol Inflamm; 2018; 26(2):239-241. PubMed ID: 27541084
[TBL] [Abstract][Full Text] [Related]
18. Sustained remission of pediatric choroidal neovascular membrane secondary to choroidal rupture with intravitreal aflibercept.
Tao BK; Pereira A; Koushan K
Can J Ophthalmol; 2024 Jun; 59(3):e293-e296. PubMed ID: 38244992
[No Abstract] [Full Text] [Related]
19. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
[No Abstract] [Full Text] [Related]
20. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
